Construction of transgenic mice into which mutant mitochondrial DNA is artificially introduced.

人工引入突变线粒体 DNA 的转基因小鼠的构建。

基本信息

项目摘要

mtDNA with a point mutation in the tRNA^<Ile> gene at nucleotide position 4269 found in a patient with fatal cardiomyopathy and mtDNA with a point mutation in the tRNA^<Arg> gene at 10410 found in a patient with Alpers disease were transferred cytoplasmically to rho゚ HeLa cells (HeLa cells lacking mtDNA) to determine whether these novel mtDNA mutations in the tRNA genes are responsible for the defects in mitochondrial respiration function observed in these diseases. Cybrid clones (clones of rho゚ HeLa cells with mtDNA from the patients) were isolated, and respiratory function and morphology of the mitochondria of the cybrid clones containing wild-type mtDNA and mutant mtDNA predominantly were compared. The results showed that accumulation of mutant mtDNA at 4269 alone without defects in the nuclear genome was sufficient to produce a disease phenotype, while mutant mtDNA at 10410 was not related to pathogenesis and reflected one of the rare polymorphic sites of human mtDNA.Moreover, we found that mitochondria in living cells were significantly swollen only when they contained predominantly the pathogenic mutant mtDNA,suggesting that the functional abnormalitiy of mitochondria induced by pathogenic mtDNA mutations in tRNA genes is always associated with their swollen structure.
将<Ile>在患有致命性心肌病的患者中发现的在tRNA 4基因的核苷酸位置4269处具有点突变的mtDNA和在<Arg>患有Alpers病的患者中发现的在tRNA 4基因的10410处具有点突变的mtDNA通过细胞质转移到rho-HeLa细胞(缺少mtDNA的HeLa细胞)中,以确定这些在tRNA 4基因中的新的mtDNA突变是否是在这些疾病中观察到的线粒体呼吸功能缺陷的原因。分离胞质杂交体克隆(rho-HeLa细胞与来自患者的mtDNA的克隆),并比较主要含有野生型mtDNA和突变型mtDNA的胞质杂交体克隆的呼吸功能和线粒体形态。结果表明,在核基因组中没有缺陷的mtDNA 4269位突变体单独积累就足以产生疾病表型,而mtDNA 10410位突变体与发病无关,反映了人类mtDNA的一种罕见多态性位点。此外,我们发现,活细胞中的线粒体只有在主要含有致病突变体mtDNA时才显著肿胀,提示致病性mtDNA tRNA基因突变引起的线粒体功能异常往往与线粒体肿胀结构有关。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawashima, S., Ohta, S., Kagawa, Y., Yoshida, M., Nishizawa, M.: "Widespread tissue distribution of multiple mitochondrial DNA deletions in familial mitochondrial myopathy" Muscle and Nerve. 17. 741-746 (1994)
Kawashima, S.、Ohta, S.、Kakawa, Y.、Yoshida, M.、Nishizawa, M.:“家族性线粒体肌病中多个线粒体 DNA 缺失的广泛组织分布”肌肉和神经。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuda, C., Endo, H., Ohta, S.and Kagawa, Y.: "Gene structure of human mitochondrial ATP synthase g-subunit ; Tissue specificity produced by RNA splicing.categorization of patients in Long-Ter" J.Biol.Chem.268. 24950-24958 (1993)
Matsuda, C.、Endo, H.、Ohta, S. 和 Kakawa, Y.:“人线粒体 ATP 合酶 g 亚基的基因结构;RNA 剪接产生的组织特异性。长期患者的分类” J.Biol
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi,J-I.,他: "Accumulation of mtDNA with a mutaion at position 3271 in tRNA-Leu(UUR)gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function" Biochem Biophys.Res.Commun.197
Hayashi, J-I. 等人:“从 MELAS 患者引入的 tRNA-Leu(UUR) 基因中 3271 位突变的 mtDNA 累积到缺乏 mtDNA 的 HeLa 细胞中,导致线粒体呼吸功能进行性抑制” Biochem Biophys.Res .通讯.197
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kabayashi,Y.: "The mutant mitochondrial genes in mitochondrial myopathy,encepholopathy,lactic acidosis and stroke-like episodes (MELAS)were selectively amplified through generations." J.Inher.Metab.Dis.15. 803-808 (1992)
Kabayashi,Y.:“线粒体肌病、脑病、乳酸性酸中毒和中风样发作 (MELAS) 中的突变线粒体基因经过几代人选择性扩增。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shiraiwa N., Ishii A., Iwamoto H., Mizusawa H., Kagawa Y.and Ohta S.: "Content of mutant mitochondrial DNA and organ-dysfunction in a patient with a MELAS-subgroup of mitochondrial encephalomyopathies." J.Neurol.Sci.120. 174-179 (1993)
Shiraiwa N.、Ishii A.、Iwamoto H.、Mizusawa H.、Kakawa Y.和 Ohta S.:“线粒体脑肌病 MELAS 亚组患者中突变线粒体 DNA 的含量和器官功能障碍。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHTA Shigeo其他文献

OHTA Shigeo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHTA Shigeo', 18)}}的其他基金

Protective effects of hydrogen against irradiation
氢气对辐射的防护作用
  • 批准号:
    24651055
  • 财政年份:
    2012
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Preventive effects of geriatric and life-style related diseases by oral administration of a novel hydrogen-producing material
口服新型产氢材料对老年和生活方式相关疾病的预防作用
  • 批准号:
    23300257
  • 财政年份:
    2011
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development toward preventive application of molecular hydrogen with a novel concept for lifestyle-related diseases
以新概念开发分子氢预防性应用,治疗生活方式相关疾病
  • 批准号:
    20300230
  • 财政年份:
    2008
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for brain infarction using a cell-penetrating protein exhibiting enhanced anti-cell death activity
使用具有增强抗细胞死亡活性的细胞穿透蛋白开发脑梗塞新疗法
  • 批准号:
    16390257
  • 财政年份:
    2004
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aldehydes accumulated in mitochondria as risk factors to neurodegenerative diseases
线粒体中积累的醛是神经退行性疾病的危险因素
  • 批准号:
    12470144
  • 财政年份:
    2000
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of the higher function of RNA molecules
RNA分子高级功能的分子基础
  • 批准号:
    09278104
  • 财政年份:
    1997
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (A)
STUDIES ON THE DEVELOPMENT OF METHODS TO REMOVE THE MUTANT MITOCHONDRIAL GENOME FOR THERAPY OF MITOCHONDRIAL DESEASE
开发去除突变线粒体基因组用于治疗线粒体疾病的方法的研究
  • 批准号:
    08457196
  • 财政年份:
    1996
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Pathology on Mitochondrial Encepholomyopathy
线粒体脑肌病的分子病理学
  • 批准号:
    04670151
  • 财政年份:
    1992
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Cloning Regulatory Genes for Proliferation of Mitochondria and Effects on Mitochondrial Disease
克隆线粒体增殖调控基因及其对线粒体疾病的影响
  • 批准号:
    01570141
  • 财政年份:
    1989
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease
小胶质细胞免疫-氧甾醇25-羟基胆固醇在阿尔茨海默病P301S tau转基因小鼠模型中介导神经炎症和神经变性中的作用
  • 批准号:
    10645467
  • 财政年份:
    2023
  • 资助金额:
    $ 11.84万
  • 项目类别:
Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer
通过建立新的前列腺癌转基因小鼠模型来表征新型前列腺癌因子接触蛋白 1 (CNTN1) 衍生的肿瘤发生
  • 批准号:
    488928
  • 财政年份:
    2023
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Operating Grants
To study the molecular oncogenesis of congenital Neurocutaneous melanocytosis in a preclinical transgenic mouse model
研究临床前转基因小鼠模型中先天性神经皮肤黑素细胞增多症的分子肿瘤发生
  • 批准号:
    10651336
  • 财政年份:
    2023
  • 资助金额:
    $ 11.84万
  • 项目类别:
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP
用于研究 HIV-1 反义蛋白 ASP 的诱导型和细胞特异性转基因小鼠模型
  • 批准号:
    10683237
  • 财政年份:
    2022
  • 资助金额:
    $ 11.84万
  • 项目类别:
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP
用于研究 HIV-1 反义蛋白 ASP 的诱导型和细胞特异性转基因小鼠模型
  • 批准号:
    10547001
  • 财政年份:
    2022
  • 资助金额:
    $ 11.84万
  • 项目类别:
Use of a novel transgenic mouse model to probe the molecular mechanisms of lipoprotein(a) pathogenicity in atherosclerosis
使用新型转基因小鼠模型探讨脂蛋白(a)致病性的分子机制
  • 批准号:
    463343
  • 财政年份:
    2022
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Operating Grants
Reduced allelic dosage of CLP1 attenuates cognitive dysfunction and pathological burden in transgenic mouse models of Alzheimer’s disease
减少 CLP1 等位基因剂量可减轻阿尔茨海默病转基因小鼠模型的认知功能障碍和病理负担
  • 批准号:
    10572250
  • 财政年份:
    2022
  • 资助金额:
    $ 11.84万
  • 项目类别:
Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of Tauopathies
研究 Tau蛋白病转基因小鼠模型中神经变性的机制
  • 批准号:
    10372933
  • 财政年份:
    2021
  • 资助金额:
    $ 11.84万
  • 项目类别:
Use of a novel transgenic mouse model to probe the molecular mechanisms of lipoprotein(a) pathogenicity in atherosclerotic vascular disease
使用新型转基因小鼠模型探讨脂蛋白(a)在动脉粥样硬化性血管疾病中致病性的分子机制
  • 批准号:
    458698
  • 财政年份:
    2021
  • 资助金额:
    $ 11.84万
  • 项目类别:
    Studentship Programs
Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of Tauopathies
研究 Tau蛋白病转基因小鼠模型中神经变性的机制
  • 批准号:
    10617695
  • 财政年份:
    2021
  • 资助金额:
    $ 11.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了